Map kinase inhibitors

被引：0
|
作者：
不详
机构：
来源：
CHIMICA OGGI-CHEMISTRY TODAY | 1998年 / 16卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [21] PHOSPHORYLATION OF XENOPUS MITOGEN-ACTIVATED PROTEIN (MAP) KINASE KINASE BY MAP KINASE KINASE KINASE AND MAP KINASE
    MATSUDA, S
    GOTOH, Y
    NISHIDA, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (05) : 3277 - 3281
  • [22] Evaluation of EGF receptor tyrosine kinase inhibitors identifies a potential selective inhibitor of MAP kinase
    Edwards, J
    Gibb, CS
    Robins, D
    Bartlett, JMS
    BRITISH JOURNAL OF CANCER, 1998, 78 (02) : 151 - 152
  • [23] Dual- action kinase inhibitors influence p38α MAP kinase dephosphorylation
    Stadnicki, Emily J.
    Ludewig, Hannes
    Kumar, Ramasamy P.
    Wang, Xicong
    Qiao, Youwei
    Kern, Dorothee
    Bradshaw, Niels
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2025, 122 (01)
  • [24] Theoretical and experimental design of atypical kinase inhibitors: Application to p38 MAP kinase
    McClure, KF
    Abramov, YA
    Laird, ER
    Barberia, JT
    Cai, WL
    Carty, TJ
    Cortina, SR
    Danley, DE
    Dipesa, AJ
    Donahue, KM
    Dombroski, MA
    Elliott, NC
    Gabel, CA
    Han, SG
    Hynes, TR
    LeMotte, PK
    Mansour, MN
    Marr, ES
    Letavic, MA
    Pandit, J
    Ripin, DB
    Sweeney, FJ
    Tan, D
    Tao, Y
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (18) : 5728 - 5737
  • [25] MEDI 356-P38 MAP kinase naphthyridinone inhibitors
    Ruzek, Rowena
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [26] Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
    Eskiocak, Ugur
    Ramesh, Vijayashree
    Gill, Jennifer G.
    Zhao, Zhiyu
    Yuan, Stacy W.
    Wang, Meng
    Vandergriff, Travis
    Shackleton, Mark
    Quintana, Elsa
    Johnson, Timothy M.
    DeBerardinis, Ralph J.
    Morrison, Sean J.
    NATURE COMMUNICATIONS, 2016, 7
  • [27] P38 α map kinase inhibitors:: From discovery to the clinic
    Dugar, S
    Mavunkel, B
    Chakravarty, S
    Perumattam, J
    Luedtke, G
    Lu, Q
    Chen, Z
    Xu, YJ
    Protter, A
    Schreiner, G
    Almirez, R
    Scott, B
    Laney, M
    Henson, M
    Lewicki, J
    Moore, A
    Lee, S
    Brahn, E
    Liu, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U162 - U162
  • [28] New generation of p38 map kinase inhibitors.
    Singh, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U206 - U206
  • [29] Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
    Ugur Eskiocak
    Vijayashree Ramesh
    Jennifer G. Gill
    Zhiyu Zhao
    Stacy W. Yuan
    Meng Wang
    Travis Vandergriff
    Mark Shackleton
    Elsa Quintana
    Arthur E. Frankel
    Timothy M. Johnson
    Ralph J. DeBerardinis
    Sean J. Morrison
    Nature Communications, 7
  • [30] Synthesis and Evaluation of Pyridinyltriazoles as Inhibitors of p38 MAP Kinase
    Moallem, Seyed Adel
    Hadizadeh, Farzin
    Abadi, Fatemeh Abdol
    Shahraki, Mahmoud
    Shamsara, Jamal
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2012, 15 (04) : 945 - 950
12345